MYARDMS LOGIN
VERIFY ARDMS CERTIFICATION
APPLY NOW
(Outline Summary)
| # | Domain | Subdomain | Percentage |
| 1 | Anatomy and Physiology | Normal Anatomy Developmental Changes Perfusion and Function | 26% |
| 2 | Congenital Variants, Pathology, and Pathophysiology | Neonatal Brain | Head and Neck | Chest Gastrointestinal | Hepatobiliary Adrenal Glands, Pancreas, and Retroperitoneum Spleen and Peritoneal Cavity | Genitourinary System Musculoskeletal, Superficial Structures, and Hernias Neonatal Spine | Vascular and Transplants | 45% |
| 3 | Data and Protocols | Outside Data (clinical assessment, history and physical [H&P], lab values) Clinical Standards and Guidelines Measurement Techniques | 19% |
| 4 | Physics and Instrumentation | Imaging Instruments | 5% |
| 5 | Treatment and Emerging Technologies | Managing Medical Emergencies and Traumatic Injury Interventional Procedures Disinfection Emerging Technology | 5% |
(Detailed Outline)
| 1. | Anatomy and Physiology 26% |
| 1.A. | Normal Anatomy |
| 1.A.1. | Evaluate anatomy of the neonatal brain and skull |
| 1.A.2. | Evaluate anatomy of the neck and head (e.g., parotid glands, submandibular glands, thyroid) |
| 1.A.3. | Evaluate anatomy of the chest (e.g., pleural space, lung, thymus, diaphragm) |
| 1.A.4. | Evaluate anatomy of the gastrointestinal tract (e.g., esophagus, pylorus, stomach, bowel, appendix) |
| 1.A.5. | Evaluate anatomy of abdominal organs (e.g., liver, gallbladder, biliary tract, adrenal glands, pancreas, spleen) |
| 1.A.6. | Evaluate anatomy of genitourinary system (e.g., kidneys, bladder, uterus, ovaries, scrotum) |
| 1.A.7. | Evaluate musculoskeletal anatomy (e.g., hips, joints) |
| 1.A.8. | Evaluate anatomy of superficial structures (e.g., breast, abdominal wall, soft tissue) |
| 1.A.9. | Evaluate anatomy of the neonatal spine |
| 1.B. | Developmental Changes |
| 1.B.1. | Identify normal age-specific changes |
| 1.C. | Perfusion and Function |
| 1.C.1. | Evaluate peripheral vascular anatomy |
| 1.C.2. | Evaluate abdominal vascular anatomy |
| 1.C.3. | Evaluate intracranial vascular anatomy |
| 1.C.4. | Evaluate transplants |
| 2. | Congenital Variants Pathology & Pathophysiology 45% |
| 2.A. | Neonatal Brain |
| 2.A.1. | Evaluate for congenital intracranial abnormalities (e.g., Dandy-Walker malformation, holoprosencephaly, callosal agenesis) |
| 2.A.2. | Evaluate for neurocutaneous syndromes (e.g., tuberous sclerosis, Von Hippel-Lindau, Sturge-Weber) |
| 2.A.3. | Evaluate for hydrocephalus/ventriculomegaly |
| 2.A.4. | Evaluate for findings of hypoxic-ischemic insults in preterm and term infants |
| 2.A.5. | Evaluate for intracranial hemorrhage, infection, and masses |
| 2.A.6. | Evaluate for findings related to sickle cell disease |
| 2.B. | Head and Neck |
| 2.B.1. | Evaluate for neck abnormalities (e.g., thyroglossal duct cyst, brachial cleft cyst, fibromatosis colli) |
| 2.B.2. | Evaluate for thyroid abnormalities (e.g., goiter, nodules, masses, enlargement) |
| 2.C. | Chest |
| 2.C.1. | Evaluate for chest abnormalities (e.g., pleural effusion, sequestration, congenital pulmonary airway malformation, masses) |
| 2.C.2. | Evaluate for congenital diaphragmatic hernia and diaphragmatic paralysis (M-mode) |
| 2.D. | Gastrointestinal |
| 2.D.1. | Evaluate for gastrointestinal abnormalities (e.g., appendicitis, volvulus, pyloric stenosis, necrotizing enterocolitis, intussusception, masses) |
| 2.E. | Hepatobiliary |
| 2.E.1. | Evaluate for hepatobiliary disease (e.g., infection, obstruction, parenchymal liver disease, biliary atresia, hepatoblastoma) |
| 2.F. | Adrenal Glands, Pancreas, and Retroperitoneum |
| 2.F.1. | Evaluate adrenal glands for abnormalities (e.g., neuroblastoma, hyperplasia, hemorrhage) |
| 2.F.2. | Evaluate for pancreatic abnormalities (e.g., pancreatitis, cystic fibrosis, congenital anomalies, fatty replacement) |
| 2.F.3. | Evaluate retroperitoneum for masses (e.g., lymphadenopathy) |
| 2.G. | Spleen and Peritoneal Cavity |
| 2.G.1. | Evaluate for splenic abnormalities (e.g., polysplenia, infection, masses) |
| 2.G.2. | Evaluate for peritoneal cavity abnormalities (e.g., ascites, abscess) |
| 2.H. | Genitourinary System |
| 2.H.1. | Evaluate for congenital renal abnormalities (e.g., horseshoe, duplication anomalies, cystic diseases) |
| 2.H.2. | Evaluate for acquired renal abnormalities (e.g., obstruction, infection, masses) |
| 2.H.3. | Evaluate for ureter and bladder abnormalities (e.g., infection, ureterocele, urachal anomalies, obstruction, vesicoureteral reflux, masses) |
| 2.H.4. | Evaluate female genital tract for abnormalities (e.g., hematometrocolpos, torsion, masses) |
| 2.H.5. | Evaluate male genital tract for abnormalities (e.g., infection, hydroceles, cryptorchidism, torsion) |
| 2.I. | Musculoskeletal, Superficial Structures, and Hernias |
| 2.I.1. | Evaluate the hip for developmental dysplasia |
| 2.I.2. | Evaluate for joint effusion in hips or other joints |
| 2.I.3. | Evaluate tendons and synovium for abnormalities (e.g., tenosynovitis, synovial hypertrophy) |
| 2.I.4. | Evaluate superficial structures for abnormalities (e.g., foreign bodies, infections, masses) |
| 2.I.5. | Evaluate glands and soft tissues for abnormalities (e.g., infection, lymph nodes, masses) |
| 2.I.6. | Evaluate for hernias (e.g., direct, indirect, inguinal) |
| 2.J. | Neonatal Spine |
| 2.J.1 | Evaluate for spinal malformations (e.g., tethered cord, myelomeningocele, caudal regression) |
| 2.K. | Vascular and Transplants |
| 2.K.1. | Evaluate for peripheral vascular malformations |
| 2.K.2. | Evaluate for abdominal vascular malformations |
| 2.K.3. | Evaluate for intracranial vascular malformations |
| 2.K.4. | Evaluate vessels and intravascular lines for abnormalities (e.g., thrombosis, pseudoaneurysm, stenosis) |
| 2.K.5. | Evaluate transplant complications (e.g., thrombus, stenosis) |
| 3. | Data and Protocols 19% |
| 3.A. | Outside Data (clinical assessment, history and physical [H&P], lab values) |
| 3.A.1. | Verify appropriateness of the order and obtain pertinent clinical history from the patient and/ or medical records (including previous imaging) |
| 3.A.2. | Assess relevant patient signs and symptoms for examination being performed |
| 3.A.3. | Explain examination requirements to patient (positioning, gel application, transducer pressure) |
| 3.B. | Clinical Standards and Guidelines |
| 3.B.1. | Communicate examination preparation requirements (e.g., fasting, bladder filling) |
| 3.B.2. | Modify imaging protocols based on clinical history and/or sonographic findings (e.g., premature, critically ill, uncooperative patients) |
| 3.B.3. | Utilize multiple patient positions |
| 3.B.4. | Utilize appropriate acoustic windows and scanning planes |
| 3.B.5. | Communicate ultrasound findings and relevant patient information to interpreting healthcare provider |
| 3.C. | Measurement Techniques |
| 3.C.1. | Obtain appropriate measurements |
| 3.C.2. | Obtain Doppler velocities and measurements |
| 4. | Physics and Instrumentation 5% |
| 4.A. | Imaging Instruments |
| 4.A.1. | Select appropriate examination techniques (e.g., M-mode, B-mode, Doppler, harmonic imaging) |
| 4.A.2. | Adjust console settings to optimize images (e.g., depth settings, artifact recognition, artifact correction when appropriate) |
| 4.A.3. | Apply as low as reasonably achievable (ALARA) principle (e.g., thermal index, mechanical index) |
| 5. | Treatment and Emerging Technology 5% |
| 5.A. | Managing Medical Emergencies and Traumatic Injury |
| 5.A.1. | Recognize findings that require immediate attention |
| 5.A.2. | Evaluate for abnormalities due to traumatic events |
| 5.B. | Interventional Procedures |
| 5.B.1. | Assist/support ultrasound guidance during interventional procedures |
| 5.B.2. | Evaluate for post-procedure changes |
| 5.C. | Disinfection |
| 5.C.1. | Maintain infection control (e.g., low-level disinfection techniques, high-level disinfection techniques, sterile techniques) |
| 5.D. | Emerging Technology |
| 5.D.1. | Recognize emerging technology applications (e.g., elastography, contrast) |
Click here to view the PDF version.